The persistence of anti-spike antibodies following two sars-cov-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls—a prospective cohort study

HIGHLIGHTS

• who: Ingrid Egeland Christensen from the Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo have published the Article: The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controlsu2014a prospective cohort study, in the Journal: (JOURNAL)
• what: The aim of this study was to compare the persistence of anti-Spike antibodies following two-dose SARS-CoV-2 vaccination between IMID patients and healthy controls and to identify factors associated with antibody decline. The authors included patients and healthy controls who provided . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.